Healthcare Artificial Intelligence (AI) Market Research Report - Global Forecast till 2027

Healthcare Artificial Intelligence (AI) Market Research Report: Information By Component (Hardware, Software, Services), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Dosage Error Reduction, Clinical Trial, Preliminary Diagnosis, Automated Image Diagnosis), Technology (Machine Learning, Querying Method, Natural Language Processing), End User (Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology Companies Academic & Research Laboratories) - Global Forecast till 2027

ID: MRFR/HCIT/4226-CR | February 2021 | Region: Global | 144 pages

AI in Healthcare Market Overview


According to MRFR, the Healthcare Artificial Intelligence Market is expected to register a CAGR of 51.9% and acquire a USD 12.22 Billion valuation by 2023 during the forecast period (2018 to 2023). For a variety of vertical markets, the emergence of artificial intelligence (AI) has been highly encouraging.


COVID-19 Analysis


The use of robotics and AI will greatly minimise the risk for transmission of coronavirus by minimising human interaction, shielding frontline health care personnel, administrative staff and the public at large, considering its extremely contagious nature and simple transmission of COVID-19 by human contact or exposed surfaces. The use of this technology by numerous pharmaceutical and biotechnology firms around the world to speed up vaccine or drug production processes for COVID-1919 is one of the main developments currently fueling healthcare artificial intelligence market growth.


Market Dynamics


Drivers


Rising Value of Big Data in Healthcare to Fuel Market Growth


The growing volume of healthcare data and increasing sophistication of datasets driving the demand for AI are the main factors driving healthcare artificial intelligence market development, the increasing need to minimise towering healthcare costs, developing computing capacity and declining hardware costs, increasing amount of cross-industry alliances and agreements, and increasing disparity between health professionals and patients driving them. Any factors driving growth are the increasing need to minimise healthcare costs, the rising value of big data in healthcare, expanded use of precision medicine, and decreased hardware costs. In addition, the growth in demand for this technology can be due to the growing applicability of AI-based instruments in medical care and the increase in venture capital investments.


Opportunities


Emerging Players in the Market to Boost Market Growth


It is expected that a growing number of cross-industry collaborations will improve AI's acceptance in the healthcare market, which is also responsible for its lucrative growth rate. Over the past few years, the number of artificial intelligence start-ups in the healthcare industry has increased dramatically and the trajectory is projected to be the same in the coming years, which would have a positive effect on the industry in turn. A main factor responsible for growing the number of these start-ups is the growth in venture capital investment in this sector.


Restraints


High Costs of AI Systems to Impede Market Growth


As healthcare institutions will not be able to utilise AI technologies without necessary licences and legal permission, stringent rules are likely to limit business expansion. In addition, since it is still a relatively modern technology, the costs of AI systems are extremely high and need high investment for all components. This systems often require frequent maintenance and repair, which often lead to the high cost of healthcare AI systems, thus hindering the development of the healthcare artificial intelligence industry. 


AI in Healthcare Market Segmental Analysis


Artificial Intelligence Market for global healthcare is segmented By Part, Application, Technology, End-User, and Region.


By Components


Components of healthcare AI are broadly segmented into hardware, software, and services. Among these at a CAGR of 52.4 percent over the review period, the hardware segment is expected to see the highest rise. Because of its need to set up the simple AI system, the segment also represents the largest share of the AI in Healthcare market.


By Applications


Applications for AI in Healthcare market are segmented into virtual nursing assistant, clinical trial, robot-assisted surgery, dosage error reduction, preliminary diagnosis, and automated image diagnosis. As it promises accuracy and precision in complicated operations, the robot-assisted surgery segment has grabbed the largest share of the global healthcare artificial intelligence industry. The automatic image diagnostic section, however, provides high potential for growth and is expected to experience the highest CAGR at 52.5% during the evaluation period.


By Technology


Technology employed in healthcare AI market is segment into machine learning, natural language processing, querying method, and others. For the projected era, the machine learning segment accounts for the largest market share and shows the highest growth potential. By allowing the system access data, machine learning allows AI systems to learn without programming, the benefits associated with this are projected to spur the growth of the segment at a CAGR of 52.4 percent.


By End-Use


End-users of AI in healthcare market are segmented into academic & research laboratories, pharmaceutical & biotechnology companies, and hospitals & diagnostic centres. The end-users for a significant number of AI implementations are anticipated to be hospitals and research centres. As such, the segment's findings show its large size and fast growth in CAGR at 52.7 percent during the forecast period.


AI in Healthcare Market Regional Analysis


The Americas, Europe, Asia Pacific and the Middle East and Africa are regions included in the AI in healthcare market survey.


Superior Healthcare Infrastructure to Boost North America Market Growth


The Americas has the highest AI in healthcare market share and is expected to be sustained over the projected period. Among the main reasons that have placed the Americas in a leading role are a rising biotechnology industry and increasing applications of robot-assisted surgery. Moreover the ageing population, the declining healthcare workers in North American countries, the growing need for better diagnostic and treatment facilities, the increase in demand for digital health systems and the significant presence in the area of major AI innovations and product developers are other factors favouring AI in healthcare market development.


Growing R&D Investments in Europe to Fuel Market Growth


Due to the continuing R&D activities conducted in the healthcare AI field, Europe accounts for the second largest sector. The area has a growth trend close to that of the Americas, and the fast acceptance of AI in healthcare supports the region's business growth.


APAC Market Accounted as the Fastest Growing Region


The Asia Pacific is a rapidly developing market which is expected to experience growth during the forecast period at a CAGR of 52.4 percent. The area has a wide number of patients who continually seek high quality therapeutic treatment for chronic diseases. Owing to rising spending, the region's healthcare sector is growing rapidly.


MEA Region to Witness Gradual Market Growth


Meanwhile, owing to the shortage of specialised healthcare facilities in much of the region, the Middle East and Africa would show sluggish growth compared with other areas. The MEA region's developing healthcare artificial intelligence market are expected to have the greatest effect on business growth.


Healthcare Artificial Intelligence Market Competitive Landscape


R&D Initiatives to be the Primary Strategy Adopted by Key Players


Probably the most critical growth plan currently being carried out by the players listed above is research and development.


In the AI sector for healthcare, IBM is ranked fourth. The company has consistently been engaged in the development and launch of AI healthcare systems for the past few years. The company has 12 research laboratories dedicated to its AI and deep-learning initiatives.


Healthcare Artificial Intelligence (AI) Market Key Players



  • DEEP GENOMICS

  • Next IT Corp

  • General Vision

  • Google

  • NVIDIA Corporation

  • IBM Watson Health

  • Intel Corporation

  • Koninklijke Philips N.V

  • GENERAL ELECTRIC

  • Stryker

  • Microsoft Corporation

  • CloudMedx Inc


Recent Development


December 2020: A six-year strategic collaboration was announced by Highmark Health and Google Cloud to leverage cloud, analytics and artificial intelligence technology to power the organization's digital health initiatives. Highmark Health, headquartered in Pittsburgh, aims to leverage the technological muscle of Google Cloud to be the breakthrough force behind the Living Health model, which is intended to provide patients with a more organised, customised, technology-enabled experience.


December 2020: NCS deployed AI-powered thermal cameras with several public healthcare providers in Singapore. The use of these cameras helped to minimise the need for manpower needed to conduct manual, one-to-one temperature measurements with handheld scanners, considering the manpower crunch at these healthcare facilities during the COVID-19 pandemic.


December 2020: GE Healthcare revealed that it would encourage consumers to search, try and purchase artificial intelligence (AI) driven apps via an online marketplace from a variety of developers from third parties. Many of the currently available applications help doctors gain insights into clinical evidence and boost results..


Report Overview


The study covered the existing short-term and long-term healthcare artificial intelligence market effect, as well as helping decision-makers to draught short-term and long-term plans for businesses by region.


By Component



  • Hardware

  • Software

  • Services


By Application



  • Robot-Assisted Surgery

  • Virtual Nursing Assistant

  • Dosage Error Reduction

  • Clinical Trial

  • Preliminary Diagnosis

  • Automated Image Diagnosis


By Technology



  • Machine Learning

  • Querying Method

  • Natural Language Processing

  • Context-Aware Computing

  • Computer Vision


By End-User



  • Hospital & Diagnostic Centers

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Laboratories



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 12.22 Billion
  CAGR   51.9% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Component, Application, Technology and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   DEEP GENOMICS, Next IT Corp, General Vision, Google, NVIDIA Corporation, IBM Watson Health, Intel Corporation, Koninklijke Philips N.V, GENERAL ELECTRIC, Stryker, Microsoft Corporation, CloudMedx Inc
  Key Market Opportunities   Emerging Players in the Market to Boost Boost Market Growth
  Key Market Drivers   Rising Value of Big Data in Healthcare to Fuel Market Growth


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


The healthcare artificial intelligence market is predicted to grow at a 51.9% CAGR between 2018-2023.

The Americas is projected to lead the healthcare artificial intelligence market during the forecast period.

It finds extensive applications in automated image diagnosis, preliminary diagnosis, clinical trial, dosage error reduction, virtual nursing assistant, and robot-assisted surgery.

Notable players profiled in the healthcare artificial intelligence market include Medtronic Plc., Stryker Corporation, General Vision, Inc., Johnson & Johnson, CloudMedx Inc., Google, Inc., Siemens Healthineers GmbH, General Electric Company, Deep Genomics, Inc., Microsoft Corporation, Intel Corporation, Intel Corporation, NVIDIA Corporation, Koninklijke Philips N.V., and IBM Corporation.

High maintenance and development cost, and data ownership and security issues may restrict market growth.

1 Report Prologue

2 Market Introduction

2.1 Scope Of Study 15

2.2 Research Objective 15

2.3 List Of Assumptions 15

3 Research Methodology

3.1 Research Process 18

3.2 Primary Research 19

3.3 Secondary Research 20

3.4 Market Size Estimation 21

4 Market Dynamics

4.1 Drivers 23

4.1.1 Increasing Adoption Of Artificial Intelligence In Research Areas 23

4.1.2 Shortage Of Health Workforce 23

4.1.3 Increase In AI Investments 23

4.2 Restraints 24

4.2.1 High Cost 24

4.2.2 Stringent Regulatory Guidelines 24

4.3 Opportunities 24

4.3.1 The Rapid Expansion Of Technology And Digital Applications In Healthcare 24

5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis 26

5.1.1 Threat Of New Entrants 26

5.1.2 Bargaining Power Of Suppliers 26

5.1.3 Threat Of Substitutes 27

5.1.4 Bargaining Power Of Buyers 27

5.1.5 Intensity Of Rivalry 27

5.2 Value Chain Analysis 28

5.2.1 Inputs 28

5.2.2 Software Development Processes 28

5.2.3 Output 29

5.2.4 Marketing And Distribution 29

5.2.5 Post-Selling Services 29

6 Global Healthcare Artificial Intelligence Market, By Component

6.1 Introduction 31

6.2 Hardware 32

6.3 Software 32

6.4 Services 32

7 Global Healthcare Artificial Intelligence Market, By Application

7.1 Introduction 34

7.2 Robot-Assisted Surgery 35

7.3 Virtual Nursing Assistant 35

7.4 Dosage Error Reduction 35

7.5 Clinical Trial 36

7.6 Preliminary Diagnosis 36

7.7 Automated Image Diagnosis 36

8 Global Healthcare Artificial Intelligence Market, By Technology

8.1 Introduction 38

8.2 Machine Learning 39

8.3 Querying Method 39

8.4 Natural Language Processing 39

9 Global Healthcare Artificial Intelligence Market, By End User

9.1 Introduction 41

9.2 Hospital & Diagnostic Centers 42

9.3 Pharmaceutical & Biotechnology Companies 42

9.4 Academic & Research Laboratories 42

10 Global Healthcare Artificial Intelligence Market, By Region

10.1 Introduction 44

10.2 Americas 45

10.2.1 North America 47

10.2.1.1 U.S 49

10.2.1.2 Canada 50

10.2.2 South America 52

10.3 Europe 54

10.3.1 Western Europe 56

10.3.1.1 Germany 58

10.3.1.2 U.K 59

10.3.1.3 France 61

10.3.1.4 Italy 62

10.3.1.5 Spain 64

10.3.1.6 Rest Of Western Europe 65

10.3.2 Eastern Europe 67

10.4 Asia Pacific 69

10.4.1 Japan 71

10.4.2 China 72

10.4.3 India 74

10.4.4 Australia 75

10.4.5 Republic Of Korea 77

10.4.6 Rest Of Asia Pacific 78

10.5 Middle East & Africa 80

10.5.1 Middle East 82

10.5.2 Africa 83

11 Competitive Landscape

11.1 Introduction 86

12 Company Profiles

12.1 DEEP GENOMICS 88

12.1.1 Company Overview 88

12.1.2 Financial Overview 88

12.1.3 Products Offering 88

12.1.4 Key Developments 88

12.1.5 SWOT Analysis 88

12.1.6 Key Strategy 88

12.2 Next IT Corp. 89

12.2.1 Company Overview 89

12.2.2 Financial Overview 89

12.2.3 Products Offering 90

12.2.4 Key Developments 90

12.2.5 SWOT Analysis 90

12.2.6 Key Strategy 90

12.3 General Vision 91

12.3.1 Company Overview 91

12.3.2 Financial Overview 91

12.3.3 Products 91

12.3.4 Key Developments 91

12.3.5 SWOT Analysis 91

12.3.6 Key Strategy 91

12.4 Google 92

12.4.1 Company Overview 92

12.4.2 Financial Overview 92

12.4.3 Products/Services Offering 93

12.4.4 Key Developments 93

12.4.5 SWOT Analysis 93

12.4.6 Key Strategy 93

12.5 NVIDIA Corporation 94

12.5.1 Company Overview 94

12.5.2 Financial Overview 94

12.5.3 Products Offering 95

12.5.4 Key Developments 95

12.5.5 SWOT Analysis 95

12.5.6 Key Strategy 95

12.6 IBM Watson Health 96

12.6.1 Company Overview 96

12.6.2 Financial Overview 96

12.6.3 Products Offering 97

12.6.4 Key Developments 97

12.6.5 SWOT Analysis 97

12.6.6 Key Strategy 97

12.7 Intel Corporation 98

12.7.1 Company Overview 98

12.7.2 Financial Overview 98

12.7.3 Products Offering 99

12.7.4 Key Developments 99

12.7.5 SWOT Analysis 99

12.7.6 Key Strategy 99

12.8 Koninklijke Philips N.V. 100

12.8.1 Company Overview 100

12.8.2 Financial Overview 100

12.8.3 Products Offering 101

12.8.4 Key Developments 101

12.8.5 SWOT Analysis 101

12.8.6 Key Strategy 101

12.9 GENERAL ELECTRIC 102

12.9.1 Company Overview 102

12.9.2 Financial Overview 102

12.9.3 Products Offering 103

12.9.4 Key Developments 103

12.9.5 SWOT Analysis 103

12.9.6 Key Strategy 104

12.10 Stryker 105

12.10.1 Company Overview 105

12.10.2 Financial Overview 105

12.10.3 Products Offering 106

12.10.4 Key Developments 106

12.10.5 SWOT Analysis 106

12.10.6 Key Strategy 106

12.11 Microsoft Corporation 107

12.11.1 Company Overview 107

12.11.2 Financial Overview 107

12.11.3 Products Offering 108

12.11.4 Key Developments 108

12.11.5 SWOT Analysis 108

12.11.6 Key Strategy 108

12.12 CloudMedx Inc. 109

12.12.1 Company Overview 109

12.12.2 Financial Overview 109

12.12.3 Products Offering 109

12.12.4 Key Developments 109

12.12.5 SWOT Analysis 109

12.12.6 Key Strategy 110

13 Appendix

13.1 Discussion Blue Print 112

14 List Of Tables

TABLE 1 LIST OF ASSUMPTIONS 15

TABLE 2 PRIMARY INTERVIEWS 18

TABLE 3 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 31

TABLE 4 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR HARDWARE BY REGION 2020-2027 (USD MILLION) 32

TABLE 5 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR SOFTWARE BY REGION 2020-2027 (USD MILLION) 32

TABLE 6 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR SERVICES BY REGION 2020-2027 (USD MILLION) 32

TABLE 7 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 34

TABLE 8 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR ROBOT-ASSISTED SURGERY BY REGION

2020-2027 (USD MILLION) 35

TABLE 9 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR VIRTUAL NURSING ASSISTANT BY REGION

2020-2027 (USD MILLION) 35

TABLE 10 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR DOSAGE ERROR REDUCTION BY REGION

2020-2027 (USD MILLION) 35

TABLE 11 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR CLINICAL TRIAL BY REGION 2020-2027 (USD MILLION) 36

TABLE 12 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR PRELIMINARY DIAGNOSIS BY REGION

2020-2027 (USD MILLION) 36

TABLE 13 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR AUTOMATED IMAGE DIAGNOSIS BY REGION

2020-2027 (USD MILLION) 36

TABLE 14 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 38

TABLE 15 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR MACHINE LEARNING BY REGION 2020-2027 (USD MILLION) 39

TABLE 16 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR QUERYING METHOD BY REGION 2020-2027 (USD MILLION) 39

TABLE 17 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR NATURAL LANGUAGE PROCESSING BY REGION

2020-2027 (USD MILLION) 39

TABLE 18 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 41

TABLE 19 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR HOSPITAL & DIAGNOSTIC CENTERS BY REGION

2020-2027 (USD MILLION) 42

TABLE 20 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

BY REGION 2020-2027 (USD MILLION) 42

TABLE 21 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET FOR ACADEMIC & RESEARCH LABORATORIES BY REGION

2020-2027 (USD MILLION) 42

TABLE 22 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY REGION 2020-2027 (USD MILLION) 44

TABLE 23 AMERICAS HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY REGION 2020-2027 (USD MILLION) 45

TABLE 24 AMERICAS HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 45

TABLE 25 AMERICAS HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 46

TABLE 26 AMERICAS HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 46

TABLE 27 AMERICAS HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 46

TABLE 28 NORTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COUNTRY 2020-2027 (USD MILLION) 47

TABLE 29 NORTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 47

TABLE 30 NORTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 47

TABLE 31 NORTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 48

TABLE 32 NORTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 48

TABLE 33 U.S HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 49

TABLE 34 U.S HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 49

TABLE 35 U.S HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 49

TABLE 36 U.S HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 50

TABLE 37 CANADA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 50

TABLE 38 CANADA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 50

TABLE 39 CANADA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 51

TABLE 40 CANADA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 51

TABLE 41 SOUTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 52

TABLE 42 SOUTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 52

TABLE 43 SOUTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 52

TABLE 44 SOUTH AMERICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 53

TABLE 45 EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY REGION 2020-2027 (USD MILLION) 54

TABLE 46 EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 54

TABLE 47 EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 55

TABLE 48 EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 55

TABLE 49 EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 55

TABLE 50 WESTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COUNTRY2020-2027 (USD MILLION) 56

TABLE 51 WESTEN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 56

TABLE 52 WESTEN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 56

TABLE 53 WESTEN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 57

TABLE 54 WESTEN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 57

TABLE 55 GERMANY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 58

TABLE 56 GERMANY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 58

TABLE 57 GERMANY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 58

TABLE 58 GERMANY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 59

TABLE 59 U.K HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 59

TABLE 60 U.K HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 59

TABLE 61 U.K HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 60

TABLE 62 U.K HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 60

TABLE 63 FRANCE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 61

TABLE 64 FRANCE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 61

TABLE 65 FRANCE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 61

TABLE 66 FRANCE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 62

TABLE 67 ITALY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 62

TABLE 68 ITALY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 62

TABLE 69 ITALY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 63

TABLE 70 ITALY HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 63

TABLE 71 SPAIN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 64

TABLE 72 SPAIN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 64

TABLE 73 SPAIN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 64

TABLE 74 SPAIN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 65

TABLE 75 REST OF WESTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 65

TABLE 76 REST OF WESTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 65

TABLE 77 REST OF WESTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 66

TABLE 78 REST OF WESTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 66

TABLE 79 EASTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 67

TABLE 80 EASTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 67

TABLE 81 EASTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 67

TABLE 82 EASTERN EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 68

TABLE 83 ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COUNTRY 2020-2027 (USD MILLION) 69

TABLE 84 ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 69

TABLE 85 ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 70

TABLE 86 ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 70

TABLE 87 ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 70

TABLE 88 JAPAN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 71

TABLE 89 JAPAN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 71

TABLE 90 JAPAN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 71

TABLE 91 JAPAN HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 72

TABLE 92 CHINA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 72

TABLE 93 CHINA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 72

TABLE 94 CHINA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 73

TABLE 95 CHINA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 73

TABLE 96 INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 74

TABLE 97 INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 74

TABLE 98 INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 74

TABLE 99 INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 75

TABLE 100 AUSTRALIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 75

TABLE 101 AUSTRALIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 75

TABLE 102 AUSTRALIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 76

TABLE 103 AUSTRALIA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 76

TABLE 104 REPUBLIC OF KOREA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 77

TABLE 105 REPUBLIC OF KOREA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 77

TABLE 106 REPUBLIC OF KOREA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 77

TABLE 107 REPUBLIC OF KOREA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 78

TABLE 108 REST OF ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 78

TABLE 109 REST OF ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 78

TABLE 110 REST OF ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 79

TABLE 111 REST OF ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 79

TABLE 112 MIDDLE EAST & AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY REGION 2020-2027 (USD MILLION) 80

TABLE 113 MIDDLE EAST & AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 80

TABLE 114 MIDDLE EAST & AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 81

TABLE 115 MIDDLE EAST & AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 81

TABLE 116 MIDDLE EAST & AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 81

TABLE 117 MIDDLE EAST HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 82

TABLE 118 MIDDLE EAST HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 82

TABLE 119 MIDDLE EAST HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 82

TABLE 120 MIDDLE EAST HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 83

TABLE 121 AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020-2027 (USD MILLION) 83

TABLE 122 AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 83

TABLE 123 AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 84

TABLE 124 AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020-2027 (USD MILLION) 84

TABLE 125 TOP PLAYERS IN THE GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET 2020 86

15 List Of Figures

FIGURE 1 GLOBAL HEALTHCARE ARTIFICAL INTELLIGENCE MARKET: MARKET STRUCTURE 16

FIGURE 2 RESEARCH PROCESS 18

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 21

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HEALTHCARE AI MARKET 26

FIGURE 5 VALUE CHAIN ANALYSIS: HEALTHCARE AI MARKET 28

FIGURE 6 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY COMPONENT 2020 & 2027 (USD MILLION) 31

FIGURE 7 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 34

FIGURE 8 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY 2020 & 2027 (USD MILLION) 38

FIGURE 9 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET, BY END USER 2020 & 2027 (USD MILLION) 41

FIGURE 10 GLOBAL HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET SHARE, BY REGION 2020 (%) 44

FIGURE 11 AMERICAS HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET SHARE, BY REGION 2020 (%) 45

FIGURE 12 EUROPE HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET SHARE, BY REGION 2020 (%) 54

FIGURE 13 ASIA PACIFIC HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET SHARE, BY REGION 2020 (%) 69

FIGURE 14 MIDDLE EAST & AFRICA HEALTHCARE ARTIFICIAL INTELLIGENCE MARKET SHARE, BY REGION 2020 (%) 80

Global Healthcare Artificial Intelligence Market: Competitive Landscape


The top companies operating in the global healthcare artificial intelligence market include Google, IBM, Intel Corporation, Microsoft Corporation. These companies continue to retain their strong global presence through expansion, merger & acquisition, and extensive product portfolio.


The global healthcare artificial intelligence market is characterized by the presence of many global, regional, and local vendors. The market is competitive with all the players competing to gain a presence in the market. Intense competition, rapid advances in technology, frequent changes in government policies, and regulations are key factors that confront the market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products and services to survive and succeed in an intensely competitive market environment.


The growth of healthcare artificial intelligence market vendors is dependent on market conditions, government support, and industry development. Thus, vendors should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players are likely to strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that the improvement of the global economic scenario combined with efforts to enhance the infrastructure in emerging nations, is fuelling the market growth, thereby making it an ideal time for new products and increase the global market share.


The vendors with better technical and financial resources can develop innovative products. Further, research and development will play a major role in the development of a player in the market. Therefore, vendors must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their products and services in the market.


In the global healthcare artificial intelligence market, numerous companies are involved in the developing numerous softwares and cloud platform. These players have expanded their market in other regions as well. Major companies have a huge brand identity and product portfolio. These companies have adopted the organic strategy of product launches and acquisitions to gain the market. These strategy implied by the players in this market is continuous innovation and development of the new and better products to beat the opponents and strive in this big market.


Intended Audience



  • Artificial intelligence system providers

  • Healthcare software players

  • Doctors and hospitals

  • Technology providers

  • Chipset companies

  • Software solution providers

  • Research organizations and medical consulting companies

  • Venture capitalists, private equity firms, and start-up companies